Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 492

1.

A Systematic Review of Ultrasound-Detected Lipohypertrophy in Insulin-Exposed People with Diabetes.

Abu Ghazaleh H, Hashem R, Forbes A, Dilwayo TR, Duaso M, Sturt J, Halson-Brown S, Mulnier H.

Diabetes Ther. 2018 Jul 16. doi: 10.1007/s13300-018-0472-7. [Epub ahead of print] Review.

PMID:
30014243
2.

Characteristics of Dapagliflozin Responders: A Longitudinal, Prospective, Nationwide Dapagliflozin Surveillance Study in Korea.

Han E, Kim A, Lee SJ, Kim JY, Kim JH, Lee WJ, Lee BW.

Diabetes Ther. 2018 Jul 11. doi: 10.1007/s13300-018-0470-9. [Epub ahead of print]

PMID:
29998370
3.
4.

Switching From Pre-mixed Insulin to Regimens with Insulin Glargine in Type 2 Diabetes: A Prospective, Observational Study of Data From Adriatic Countries.

Petrovski G, Gjergji D, Grbic A, Vukovic B, Krajnc M, Grulovic N.

Diabetes Ther. 2018 Jul 3. doi: 10.1007/s13300-018-0467-4. [Epub ahead of print]

PMID:
29971748
5.

Glycemic Control in Hospitalized Patients with Diabetes Receiving Corticosteroids Using a Neutral Protamine Hagedorn Insulin Protocol: A Randomized Clinical Trial.

Khowaja A, Alkhaddo JB, Rana Z, Fish L.

Diabetes Ther. 2018 Jun 30. doi: 10.1007/s13300-018-0468-3. [Epub ahead of print]

PMID:
29961246
6.

Turkish Insulin Injection Technique Study: Population Characteristics of Turkish Patients with Diabetes Who Inject Insulin and Details of Their Injection Practices as Assessed by Survey Questionnaire.

Dagdelen S, Deyneli O, Olgun N, Siva ZO, Sargin M, Hatun S, Kulaksizoglu M, Kaya A, Gürlek CA, Hirsch LJ, Strauss KW; ITQ Turkish Study Group.

Diabetes Ther. 2018 Jun 30. doi: 10.1007/s13300-018-0464-7. [Epub ahead of print]

PMID:
29961245
7.

Turkish Insulin Injection Techniques Study: Complications of Injecting Insulin Among Turkish Patients with Diabetes, Education They Received, and the Role of Health Care Professional as Assessed by Survey Questionnaire.

Dagdelen S, Deyneli O, Olgun N, Siva ZO, Sargin M, Hatun S, Kulaksizoglu M, Kaya A, Gürlek CA, Hirsch LJ, Strauss KW; ITQ Turkish Study Group.

Diabetes Ther. 2018 Jun 30. doi: 10.1007/s13300-018-0463-8. [Epub ahead of print]

PMID:
29961244
8.

Contribution of BHG and PPHG to Overall Hyperglycemia in T2DM Patients Treated with LM25 and LM50: Post Hoc Analysis of a Randomized Crossover Trial.

Li W, Ping F, Xu L, Zhang H, Dong Y, Li H, Sun Q, Li Y.

Diabetes Ther. 2018 Jun 27. doi: 10.1007/s13300-018-0462-9. [Epub ahead of print]

PMID:
29951978
9.

Cerebral Biochemical Effect of Pregabalin in Patients with Painful Diabetic Neuropathy: A Randomized Controlled Trial.

De Jaeger M, Goudman L, Van Schuerbeek P, De Mey J, Keymeulen B, Brouns R, Moens M.

Diabetes Ther. 2018 Jun 27. doi: 10.1007/s13300-018-0460-y. [Epub ahead of print]

PMID:
29951977
10.

A Randomized Controlled Trial of Dapagliflozin Plus Once-Weekly Exenatide Versus Placebo in Individuals with Obesity and Without Diabetes: Metabolic Effects and Markers Associated with Bodyweight Loss.

Pereira MJ, Lundkvist P, Kamble PG, Lau J, Martins JG, Sjöström CD, Schnecke V, Walentinsson A, Johnsson E, Eriksson JW.

Diabetes Ther. 2018 Jun 13. doi: 10.1007/s13300-018-0449-6. [Epub ahead of print]

PMID:
29949016
11.

Long-Term Effect of the Color Record Method in Self-Monitoring of Blood Glucose on Metabolic Parameters in Type 2 Diabetes: A 2-Year Follow-up of the Color IMPACT Study.

Nishimura A, Harashima SI, Hosoda K, Inagaki N.

Diabetes Ther. 2018 Jun 12. doi: 10.1007/s13300-018-0457-6. [Epub ahead of print]

PMID:
29949015
12.

Cardiovascular Safety of Empagliflozin Versus Dipeptidyl Peptidase-4 (DPP-4) Inhibitors in Type 2 Diabetes: Systematic Literature Review and Indirect Comparisons.

Balijepalli C, Shirali R, Kandaswamy P, Ustyugova A, Pfarr E, Lund SS, Druyts E.

Diabetes Ther. 2018 Jun 12. doi: 10.1007/s13300-018-0456-7. [Epub ahead of print]

PMID:
29949014
13.

Efficacy and Safety of Sitagliptin in Hispanic/Latino Patients with Type 2 Diabetes: A Pooled Analysis from Ten Randomized, Placebo-Controlled Phase 3 Clinical Trials.

Raji A, Long J, Lam RLH, O'Neill EA, Engel SS.

Diabetes Ther. 2018 Jun 23. doi: 10.1007/s13300-018-0461-x. [Epub ahead of print]

PMID:
29936573
14.

Diabetic Gastroparesis: Principles and Current Trends in Management.

Krishnasamy S, Abell TL.

Diabetes Ther. 2018 Jun 22. doi: 10.1007/s13300-018-0454-9. [Epub ahead of print] Review.

PMID:
29934758
15.

Correction to: Comparison of Adipose Distribution Indices with Gold Standard Body Composition Assessments in the EMPA-REG H2H SU Trial: A Body Composition Sub-Study.

Neeland IJ, McGuire DK, Eliasson B, Ridderstråle M, Zeller C, Woerle HJ, Broedl UC, Johansen OE.

Diabetes Ther. 2018 Jun 21. doi: 10.1007/s13300-018-0465-6. [Epub ahead of print]

PMID:
29931507
16.

There is a Close Association Between the Recovery of Liver Injury and Glycemic Control after SGLT2 Inhibitor Treatment in Japanese Subjects with Type 2 Diabetes: A Retrospective Clinical Study.

Kinoshita T, Shimoda M, Sanada J, Fushimi Y, Hirata Y, Irie S, Obata A, Kimura T, Hirukawa H, Kohara K, Tatsumi F, Kamei S, Nakanishi S, Mune T, Kaku K, Kaneto H.

Diabetes Ther. 2018 Jun 21. doi: 10.1007/s13300-018-0447-8. [Epub ahead of print]

PMID:
29931506
17.

Ipragliflozin Add-on Therapy to a GLP-1 Receptor Agonist in Japanese Patients with Type 2 Diabetes (AGATE): A 52-Week Open-Label Study.

Ishihara H, Yamaguchi S, Nakao I, Sakatani T.

Diabetes Ther. 2018 Jun 20. doi: 10.1007/s13300-018-0455-8. [Epub ahead of print]

PMID:
29926400
18.

Correction to: Reproducibility and Validity of a Questionnaire Measuring Treatment Burden on Patients with Type 2 Diabetes: Diabetic Treatment Burden Questionnaire (DTBQ).

Ishii H, Shin K, Tosaki T, Haga T, Nakajima Y, Shiraiwa T, Watanabe N, Koizumi M, Nakajima H, Okada S, Mashitani T, Mohri T, Akai Y.

Diabetes Ther. 2018 Jun 16. doi: 10.1007/s13300-018-0459-4. [Epub ahead of print]

PMID:
29909478
19.

Semaglutide s.c. Once-Weekly in Type 2 Diabetes: A Population Pharmacokinetic Analysis.

Carlsson Petri KC, Ingwersen SH, Flint A, Zacho J, Overgaard RV.

Diabetes Ther. 2018 Jun 15. doi: 10.1007/s13300-018-0458-5. [Epub ahead of print]

PMID:
29907893
20.

Diabetes Fatigue Syndrome.

Kalra S, Sahay R.

Diabetes Ther. 2018 Jun 4. doi: 10.1007/s13300-018-0453-x. [Epub ahead of print]

PMID:
29869049

Supplemental Content

Loading ...
Support Center